{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:05:01Z","timestamp":1790730301443,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11655-019-3066-y","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T05:50:57Z","timestamp":1557294657000},"page":"565-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Jin-zhou","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-nian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"3066_CR1","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/S0140-6736(13)60221-4","volume":"381","author":"KY Chan","year":"2013","unstructured":"Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, et al. Epidemiology of Alzheimer\u2019s disease and other forms of dementia in China, 1990\u20132010: a systematic review and analysis. Lancet 2013;381:2016\u20132023.","journal-title":"Lancet"},{"key":"3066_CR2","volume-title":"World Alzheimer Report 2015: The global impact of dementia","author":"Alzheimer\u2019s Disease International.","year":"2015","unstructured":"Alzheimer\u2019s Disease International. World Alzheimer Report 2015: The global impact of dementia. [2015\u20139\u20131] Available at \n                    https:\/\/doi.org\/www.alz.co.uk\/research\/world-report-2015"},{"key":"3066_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","volume":"924","author":"DJ Selkoe","year":"2000","unstructured":"Selkoe DJ. Toward a comprehensive theory for Alzheimer\u2019s disease. Hypothesis: Alzheimer\u2019s disease is caused by the cerebral accumulation and cytotoxicity of amyloid betaprotein. Ann N Y Acad Sci 2000;924:17\u201325.","journal-title":"Ann N Y Acad Sci"},{"key":"3066_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 2011;7:263\u2013269.","journal-title":"Alzheimers Dement"},{"key":"3066_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/psyg.12053","volume":"14","author":"EH Kua","year":"2014","unstructured":"Kua EH, Ho E, Tan HH, Tsoi C, Thng C, Mahendran R. The natural history of dementia. Psychogeriatrics 2014;14:196\u2013201.","journal-title":"Psychogeriatrics"},{"key":"3066_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000091790","volume":"21","author":"B Winblad","year":"2006","unstructured":"Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, et al. Three-year study of donepezil therapy in Alzheimer\u2019s disease: effects of early and continuous therapy. Dement Geriatr Cogn Disord 2006;21:353\u2013363.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"3066_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/gps.1746","volume":"22","author":"A Burns","year":"2007","unstructured":"Burns A, Gauthier S, Perdomo C. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer\u2019s disease. Int J Geriatr Psychiatry 2007;22:806\u2013812.","journal-title":"Int J Geriatr Psychiatry"},{"key":"3066_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1106668","volume":"366","author":"R Howard","year":"2012","unstructured":"Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, et al. Donepezil and memantine for moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 2012;366:893\u2013903.","journal-title":"N Engl J Med"},{"key":"3066_CR9","first-page":"2948","volume":"33","author":"J Liu","year":"2012","unstructured":"Liu J, Wang LN, Tian J. Recognition of dementia in ancient China. Neurobiol Aging 2012;33:2948.","journal-title":"Neurobiol Aging"},{"key":"3066_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/alzrt54","volume":"2","author":"J Tian","year":"2010","unstructured":"Tian J, Shi J, Zhang XK, Wang YY. Herbal therapy: a new pathway for the treatment of Alzheimer\u2019s disease. Alzheimers Res Ther 2010;2:30.","journal-title":"Alzheimers Res Ther"},{"key":"3066_CR11","first-page":"140","volume":"131","author":"J Tian","year":"2010","unstructured":"Tian J, Shi, J, Miao Y, Mao M. A 24 week of randomized, double-blind, parallel controlled trial of GEPT extract in the treatment of amnestic mild cognitive impairment. Int J Neuropsychopharmacol 2010;131:140.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3066_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/156720509787602942","volume":"6","author":"J Tian","year":"2009","unstructured":"Tian J, Shi J, Zhang L, Yin J, Hu Q, Xu Y, et al. GEPT extract reduces A beta deposition by regulating the balance between production and degradation of A beta in APPV717I transgenic mice. Cur Alzheimer Res 2009;6:118\u2013131.","journal-title":"Cur Alzheimer Res"},{"key":"3066_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2174\/156720505774932287","volume":"2","author":"LS Schneider","year":"2005","unstructured":"Schneider LS, DeKosky ST, Farlow MR, Tariot PN, Hoerr R, Kieser M. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer\u2019s type. Cur Alzheimer Res 2005;2:541\u2013551.","journal-title":"Cur Alzheimer Res"},{"key":"3066_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jns.2009.02.353","volume":"283","author":"O Napryeyenko","year":"2009","unstructured":"Napryeyenko O, Sonnik G, Tartakovsky I. Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. J Neurol Sci 2009;283:224\u2013229.","journal-title":"J Neurol Sci"},{"key":"3066_CR15","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jpsychires.2012.03.003","volume":"46","author":"H Herrschaft","year":"2012","unstructured":"Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S. Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J Psychiatr Res 2012;46:716\u2013723.","journal-title":"J Psychiatr Res"},{"key":"3066_CR16","first-page":"99","volume-title":"Case reports of brain diseases","author":"JZ Tian","year":"2015","unstructured":"Tian JZ. Case reports of brain diseases. Beijing: People\u2019s Medical Publishing House;2015:99\u2013100."},{"key":"3066_CR17","first-page":"339","volume":"44","author":"J Shi","year":"2017","unstructured":"Shi J, Ni JN, Wei MQ, Zhang XK, Li T, Kang SH, Tian J. Association between pattern changes and cognitive outcome in Alzheimer\u2019s disease. J Beijing Univ Tradit Chin Med (Chin) 2017;44:339\u2013343.","journal-title":"J Beijing Univ Tradit Chin Med (Chin)"},{"key":"3066_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 1991;12:383\u2013388.","journal-title":"Trends Pharmacol Sci"},{"key":"3066_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamaneurol.2017.4026","volume":"75","author":"E McDade","year":"2018","unstructured":"McDade E, Bateman RJ. Tau positron emission tomography in autosomal dominant Alzheimer\u2019s disease: small windows, big picture. JAMA Neurol 2018;75:536\u2013538.","journal-title":"JAMA Neurol"},{"key":"3066_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1365-2990.2006.00732.x","volume":"132","author":"J Tian","year":"2006","unstructured":"Tian J, Shi J, Smallman R, Watsubo T, Mann DMA. Relationships in Alzheimer\u2019s disease between the extent of A\u03b2 deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol Applied Neurobiol 2006;132:332\u2013340.","journal-title":"Neuropathol Applied Neurobiol"},{"key":"3066_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-005-1108-3","volume":"111","author":"J Shi","year":"2006","unstructured":"Shi J, Tian J, Pritchard AH, Lendon C, Lambert JC, Iwatsubo T, et al. A 3\u2032-UTR polymorphism in the oxidized LDL receptor 1 gene increases A\u03b2 40 load as cerebral amyloid angiopathy in Alzheimer\u2019s disease. Acta Neuropathol 2006;111:15\u201320.","journal-title":"Acta Neuropathol"},{"key":"3066_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 2016;537:50\u201356.","journal-title":"Nature"},{"key":"3066_CR23","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","volume":"388","author":"S Gauthier","year":"2016","unstructured":"Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, et al. Efficacy and safety of tauaggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet 2016;388:2873\u20132884.","journal-title":"Lancet"},{"key":"3066_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa1705971","volume":"378","author":"LS Honig","year":"2018","unstructured":"Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, et al. Trial of Solanezumab for mild dementia due to Alzheimer\u2019s disease. N Engl J Med 2018;378:321\u2013330.","journal-title":"N Engl J Med"},{"key":"3066_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40478-015-0199-x","volume":"3","author":"AM Pooler","year":"2015","unstructured":"Pooler AM, Polydoro M, Maury EA, Nicholls SB, Reddy SM, Wegmann S, et al. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease. Acta Neuropathol Commun 2015;3:14.","journal-title":"Acta Neuropathol Commun"},{"key":"3066_CR26","doi-asserted-by":"publisher","first-page":"S611","DOI":"10.3233\/JAD-179935","volume":"64","author":"W Gulisano","year":"2018","unstructured":"Gulisano W, Maugeri D, Baltrons MA, F\u00e0 M, Amato A, Palmeri A, et al. Role of amyloid-\u03b2 and tau proteins in Alzheimer\u2019s disease: confuting the amyloid cascade. J Alzheimers Dis 2018;64:S611\u2013S631.","journal-title":"J Alzheimers Dis"},{"key":"3066_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Laurel A, Beckettc LA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 2011;7:280\u2013292.","journal-title":"Alzheimers Dement"},{"key":"3066_CR28","first-page":"28","volume":"4","author":"ZY Long","year":"2012","unstructured":"Long ZY, Shi J, Tian JZ, Wang YY. The study of symptom subtypes in dementia. Chin J Front Med Sci (Electronic Version, Chin) 2012;4:28\u201335.","journal-title":"Chin J Front Med Sci (Electronic Version, Chin)"},{"key":"3066_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3736\/jcim20090302","volume":"7","author":"YC Miao","year":"2009","unstructured":"Miao YC, Tian JZ, Shi J. Correlation between cognitive functions and syndromes of traditional Chinese medicine in amnestic mild cognitive impairment. J Chin Integr Med 2009;7:205\u2013211.","journal-title":"J Chin Integr Med"},{"key":"3066_CR30","first-page":"460562","volume":"2013","author":"J Shi","year":"2013","unstructured":"Shi J, Tian J, Long Z, Liu X, Wei M, Ni J, et al. The pattern element scale: a brief tool of traditional medical subtyping for dementia. Evid Based Complement Alternat Med 2013;2013:460562.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3066_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3736\/jcim20040201","volume":"2","author":"SH Chen","year":"2007","unstructured":"Chen SH, Chen YL, Yang ZM. Initial study on disposition of Chinese medical symptoms and signs of mild cognitive impairment for elder people. World Chin Med (Chin) 2007;2:81\u201383.","journal-title":"World Chin Med (Chin)"},{"key":"3066_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1017\/CBO9780511610714.026","volume-title":"The Cambridge handbook of age and aging","author":"J Tian","year":"2005","unstructured":"Tian J. Dementia in an Asian Context. Johnson ML. The Cambridge handbook of age and aging. Cambridge: Cambridge University Press; 2005:261\u2013273."},{"key":"3066_CR33","first-page":"122","volume-title":"Internal medicine of traditional Chinese medicine\u2022dementia","author":"JZ Tian","year":"2012","unstructured":"Tian JZ. Internal medicine of traditional Chinese medicine\u2022dementia. Beijing: People\u2019s Medical Publishing House;2012:122\u2013128."},{"key":"3066_CR34","first-page":"523","volume":"38","author":"The Joint Consensus Group of Traditional Chinese Medicine on Alzheimer\u2019s Disease.","year":"2018","unstructured":"The Joint Consensus Group of Traditional Chinese Medicine on Alzheimer\u2019s Disease. Consensus of traditional Chinese medicine specialists on Alzheimer\u2019s disease. Chin J Integr Tradit West Med (Chin) 2018;38:523\u2013529.","journal-title":"Chin J Integr Tradit West Med (Chin)"},{"key":"3066_CR35","first-page":"215","volume-title":"Chinese guidelines for the diagnosis and treatment of Alzheimer\u2019s disease and other dementias","author":"JZ Tian","year":"2018","unstructured":"Tian JZ, Xie HG, Qin B, Fan DS, Gao J, Shi J. Chinese guidelines for the diagnosis and treatment of Alzheimer\u2019s disease and other dementias. Beijing: People\u2019s Medical Publishing House;2018:215\u2013217."},{"key":"3066_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2174\/1568026615666150813143753","volume":"16","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yang G, Tian J, Liu J. Ginseng for Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. Curr Top Med Chem 2016;16:529\u2013536.","journal-title":"Curr Top Med Chem"},{"key":"3066_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12906-017-2040-5","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Ni J, Lu T, Zhang XK, Wei MQ, Li T, et al. Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer\u2019s disease: a retrospective analysis. BMC Complement Altern Med 2017;17:533\u2013539.","journal-title":"BMC Complement Altern Med"},{"key":"3066_CR38","doi-asserted-by":"publisher","first-page":"S670","DOI":"10.1016\/j.jalz.2013.05.1384","volume":"9","author":"J Tian","year":"2013","unstructured":"Tian J, Shi J, Wei MQ, Qin RA, Chen YP, On behalf of the FFDS tablets clinical study investigators. Efficacy and safety of FFDS tablets in patients with mild to moderate vascular dementia: a 24-week randomized, double-blind, placebo, parallel-controlled trial. Alzheimer Dement 2013;9:S670\u2013S671.","journal-title":"Alzheimer Dement"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-019-3066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-019-3066-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-019-3066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:38:18Z","timestamp":1588721898000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-019-3066-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3066"],"URL":"https:\/\/doi.org\/10.1007\/s11655-019-3066-y","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"assertion":[{"value":"1 March 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}